Human Milk Derived Fortifier
OtherHuman milk derived fortifier will be utilized to increase caloric intake in infants assigned to the exclusive human milk arm
NCT Number: NCT02860702
A randomized, blinded, controlled trial to evaluate growth velocity and clinical outcomes in infants with single ventricle physiology fed an exclusive human milk diet prior to, and throughout the post-operative period following, surgical repair. Human milk is defined as expressed human milk or donor milk and its derivatives, human milk-based fortifier and human milk caloric fortifier.
The study hypothesis is that infants fed an exclusive human milk diet will have short and long term benefits, with improved wound healing, growth, and neurodevelopmental outcomes while reducing episodes of feeding intolerance and necrotizing enterocolitis (NEC).
Looking for future studies?
Notify Me1 day–7 day
All sexes
Interventional
Not applicable
Loma Linda University, Loma Linda, California, United States
This is a single blinded (physician investigator), randomized, controlled trial to evaluate growth velocity and clinical outcomes in infants with single ventricle physiology fed an exclusive human milk diet during their initial hospitalization after birth and through the 30 days post-surgical repair feeding period or hospital discharge, whichever comes first.
Subjects will be randomized to one of two groups at birth or immediately following diagnosis if prenatal care was not obtained prior to birth. Parents who decline participation by their infants in the study will be asked to consent to data gathering on their infants who will be treated and fed per institutional practice. The data on these individuals will be summarized and evaluated descriptively in comparison with the actual trial results.
All patients will receive exclusive maternal human milk or donor human milk prior to randomization. Once randomized, patients in Group One will receive an exclusive human milk diet prior to the surgery and throughout the 30-day feeding period following surgical repair or until hospital discharge, whichever comes first. Day 1 is defined as the day of the first enteral feed post-surgery. Patients in Group Two (Control Group) will receive maternal human milk or formula or donor human milk (per standard of care at each hospital) in the pre-surgical period. In the post-surgical period the control group will receive human milk or formula, as per feeding algorithm The primary objective of this study is to evaluate growth velocity (weight velocity [g/kg/day] and weight z-score from World Health Organization (WHO) growth charts) at 30 days after the initiation of feed post-surgery for infants with single ventricle physiology who are fed an exclusive human milk diet from birth through the 30 day feeding period following surgical repair or until hospital discharge, whichever comes first.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Human milk derived fortifier will be utilized to increase caloric intake in infants assigned to the exclusive human milk arm
Bovine milk derived fortification
Other names: Human/Formula Milk
Time frame: 30 days
weight velocity in g/kg/day
Time frame: 30 days
weight z-score 30 days post 1st operation
Time frame: 6 months
cm/week
Time frame: 6 months
z-score
Time frame: 6 months
cm/week
Time frame: 6 months
z-score
Time frame: 30 days
defined as nil per os (NPO) for at least 24 in the 30 days of post-surgery enteral feeding period (day 1 is the first day of feeding post-op), NPO due to elective surgeries or procedures will not be defined as feeding intolerance.
Time frame: up to 24 months
time hospitalized after 1st surgery
Time frame: 30 days
Sepsis 30 days post 1st operation
Time frame: 30 days
NEC 30 days post 1st operation
Time frame: 30 days
wound infection 30 days post 1st operation
Time frame: 30 days
wound dehiscence 30 days post 1st operation
Time frame: 30 days
in days, during the 30 day post 1st operation
The University of Texas Health Science Center at San Antonio
Other
A Randomized Controlled Trial to Evaluate Growth Velocity and Clinical Outcomes of Infants With Single Ventricle Physiology Fed an Exclusive Human Milk Diet With Early Nutritional Fortification Following Surgical Repair
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04106479
Aortic Atresia, Aortic Coarctation
Montreal, Quebec, Canada
View Trial DetailsNCT01208792
Acquired Immunodeficiency Syndrome, Arthritis
Clamart, France
View Trial DetailsNCT04619745
Cardiovascular Abnormalities, Cardiovascular Diseases
Ottawa, Ontario, Canada
View Trial DetailsNCT03110861
Cardiovascular Abnormalities, Cardiovascular Diseases
Seoul, Haehak-ro Jongno-gu, South Korea
View Trial Details